Drug Delivery in Rheumatoid Arthritis

This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. To treat rheumatoid arthritis, nanotechnology-based drug delivery systems have been developed to effectively improve therapeutic efficacy over free drugs. Nanoparticles such as dendrimers, polymeric micelles, and solid lipid nanoparticles loaded with anti-arthritic drugs (such as NSAIDs, DMARDs, corticosteroids and biologics) are normally administered orally, through intravenous or intra-articular injection or via transdermal delivery.

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.